Found 6 matching trials
Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules PHASE4 The purpose of this study is to validate the user interface of TOBI Podhale...
Show More Location
Batchelor Childrens Research Institute
Learn More & Join Trial
Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™ PHASE1 This study compares pharmacokinetic profiles of tobramycin delivered by Tob...
Show More Location
Quotient Clinical
Learn More & Join Trial
Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients PHASE3 To assess whether the inhalative combination of Tobramycin/Colistin is more...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients PHASE4 The purpose of this actual use human factors (HF) study is to validate the ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs N/A This is a multicenter, prospective, two cohort, observational study over a ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI) PHASE4 The purpose of this interventional Phase IV study was to explore the ease o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial